122 related articles for article (PubMed ID: 9639429)
1. Panhandle PCR: a technical advance to amplify MLL genomic translocation breakpoints.
Felix CA; Jones DH
Leukemia; 1998 Jun; 12(6):976-81. PubMed ID: 9639429
[TBL] [Abstract][Full Text] [Related]
2. Panhandle PCR strategy to amplify MLL genomic breakpoints in treatment-related leukemias.
Megonigal MD; Rappaport EF; Jones DH; Kim CS; Nowell PC; Lange BJ; Felix CA
Proc Natl Acad Sci U S A; 1997 Oct; 94(21):11583-8. PubMed ID: 9326653
[TBL] [Abstract][Full Text] [Related]
3. Panhandle polymerase chain reaction amplifies MLL genomic translocation breakpoint involving unknown partner gene.
Felix CA; Kim CS; Megonigal MD; Slater DJ; Jones DH; Spinner NB; Stump T; Hosler MR; Nowell PC; Lange BJ; Rappaport EF
Blood; 1997 Dec; 90(12):4679-86. PubMed ID: 9389682
[TBL] [Abstract][Full Text] [Related]
4. BglII-based panhandle and reverse panhandle PCR approaches increase capability for cloning der(II) and der(other) genomic breakpoint junctions of MLL translocations.
Robinson BW; Slater DJ; Felix CA
Genes Chromosomes Cancer; 2006 Aug; 45(8):740-53. PubMed ID: 16703585
[TBL] [Abstract][Full Text] [Related]
5. Panhandle PCR for cDNA: a rapid method for isolation of MLL fusion transcripts involving unknown partner genes.
Megonigal MD; Rappaport EF; Wilson RB; Jones DH; Whitlock JA; Ortega JA; Slater DJ; Nowell PC; Felix CA
Proc Natl Acad Sci U S A; 2000 Aug; 97(17):9597-602. PubMed ID: 10920186
[TBL] [Abstract][Full Text] [Related]
6. Panhandle and reverse-panhandle PCR enable cloning of der(11) and der(other) genomic breakpoint junctions of MLL translocations and identify complex translocation of MLL, AF-4, and CDK6.
Raffini LJ; Slater DJ; Rappaport EF; Lo Nigro L; Cheung NK; Biegel JA; Nowell PC; Lange BJ; Felix CA
Proc Natl Acad Sci U S A; 2002 Apr; 99(7):4568-73. PubMed ID: 11930009
[TBL] [Abstract][Full Text] [Related]
7. Panhandle PCR approaches to cloning MLL genomic breakpoint junctions and fusion transcript sequences.
Robinson BW; Felix CA
Methods Mol Biol; 2009; 538():85-114. PubMed ID: 19277575
[TBL] [Abstract][Full Text] [Related]
8. t(11;22)(q23;q11.2) In acute myeloid leukemia of infant twins fuses MLL with hCDCrel, a cell division cycle gene in the genomic region of deletion in DiGeorge and velocardiofacial syndromes.
Megonigal MD; Rappaport EF; Jones DH; Williams TM; Lovett BD; Kelly KM; Lerou PH; Moulton T; Budarf ML; Felix CA
Proc Natl Acad Sci U S A; 1998 May; 95(11):6413-8. PubMed ID: 9600980
[TBL] [Abstract][Full Text] [Related]
9. Detection of leukemia-associated MLL-GAS7 translocation early during chemotherapy with DNA topoisomerase II inhibitors.
Megonigal MD; Cheung NK; Rappaport EF; Nowell PC; Wilson RB; Jones DH; Addya K; Leonard DG; Kushner BH; Williams TM; Lange BJ; Felix CA
Proc Natl Acad Sci U S A; 2000 Mar; 97(6):2814-9. PubMed ID: 10706619
[TBL] [Abstract][Full Text] [Related]
10. A novel chromosomal inversion at 11q23 in infant acute myeloid leukemia fuses MLL to CALM, a gene that encodes a clathrin assembly protein.
Wechsler DS; Engstrom LD; Alexander BM; Motto DG; Roulston D
Genes Chromosomes Cancer; 2003 Jan; 36(1):26-36. PubMed ID: 12461747
[TBL] [Abstract][Full Text] [Related]
11. MLL-SEPTIN6 fusion recurs in novel translocation of chromosomes 3, X, and 11 in infant acute myelomonocytic leukaemia and in t(X;11) in infant acute myeloid leukaemia, and MLL genomic breakpoint in complex MLL-SEPTIN6 rearrangement is a DNA topoisomerase II cleavage site.
Slater DJ; Hilgenfeld E; Rappaport EF; Shah N; Meek RG; Williams WR; Lovett BD; Osheroff N; Autar RS; Ried T; Felix CA
Oncogene; 2002 Jul; 21(30):4706-14. PubMed ID: 12096348
[TBL] [Abstract][Full Text] [Related]
12. Molecular analysis of 13 cases of MLL/11q23 secondary acute leukemia and identification of topoisomerase II consensus-binding sequences near the chromosomal breakpoint of a secondary leukemia with the t(4;11).
Domer PH; Head DR; Renganathan N; Raimondi SC; Yang E; Atlas M
Leukemia; 1995 Aug; 9(8):1305-12. PubMed ID: 7643617
[TBL] [Abstract][Full Text] [Related]
13. Identification of complex genomic breakpoint junctions in the t(9;11) MLL-AF9 fusion gene in acute leukemia.
Super HG; Strissel PL; Sobulo OM; Burian D; Reshmi SC; Roe B; Zeleznik-Le NJ; Diaz MO; Rowley JD
Genes Chromosomes Cancer; 1997 Oct; 20(2):185-95. PubMed ID: 9331569
[TBL] [Abstract][Full Text] [Related]
14. Distribution of 11q23 breakpoints within the MLL breakpoint cluster region in de novo acute leukemia and in treatment-related acute myeloid leukemia: correlation with scaffold attachment regions and topoisomerase II consensus binding sites.
Broeker PL; Super HG; Thirman MJ; Pomykala H; Yonebayashi Y; Tanabe S; Zeleznik-Le N; Rowley JD
Blood; 1996 Mar; 87(5):1912-22. PubMed ID: 8634439
[TBL] [Abstract][Full Text] [Related]
15. Characterization of genomic breakpoints in MLL and CBP in leukemia patients with t(11;16).
Zhang Y; Zeleznik-Le N; Emmanuel N; Jayathilaka N; Chen J; Strissel P; Strick R; Li L; Neilly MB; Taki T; Hayashi Y; Kaneko Y; Schlegelberger B; Rowley JD
Genes Chromosomes Cancer; 2004 Nov; 41(3):257-65. PubMed ID: 15334549
[TBL] [Abstract][Full Text] [Related]
16. Rearrangements involving chromosome band 11Q23 in acute leukaemia.
Rowley JD
Semin Cancer Biol; 1993 Dec; 4(6):377-85. PubMed ID: 8142623
[TBL] [Abstract][Full Text] [Related]
17. Near-precise interchromosomal recombination and functional DNA topoisomerase II cleavage sites at MLL and AF-4 genomic breakpoints in treatment-related acute lymphoblastic leukemia with t(4;11) translocation.
Lovett BD; Lo Nigro L; Rappaport EF; Blair IA; Osheroff N; Zheng N; Megonigal MD; Williams WR; Nowell PC; Felix CA
Proc Natl Acad Sci U S A; 2001 Aug; 98(17):9802-7. PubMed ID: 11493704
[TBL] [Abstract][Full Text] [Related]
18. Acute leukemias of different lineages have similar MLL gene fusions encoding related chimeric proteins resulting from chromosomal translocation.
Corral J; Forster A; Thompson S; Lampert F; Kaneko Y; Slater R; Kroes WG; van der Schoot CE; Ludwig WD; Karpas A
Proc Natl Acad Sci U S A; 1993 Sep; 90(18):8538-42. PubMed ID: 8378328
[TBL] [Abstract][Full Text] [Related]
19. An in vivo topoisomerase II cleavage site and a DNase I hypersensitive site colocalize near exon 9 in the MLL breakpoint cluster region.
Strissel PL; Strick R; Rowley JD; Zeleznik-Le NJ
Blood; 1998 Nov; 92(10):3793-803. PubMed ID: 9808573
[TBL] [Abstract][Full Text] [Related]
20. Secondary leukemias induced by topoisomerase-targeted drugs.
Felix CA
Biochim Biophys Acta; 1998 Oct; 1400(1-3):233-55. PubMed ID: 9748598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
